Ofer Agid

9.4k total citations
135 papers, 5.9k citations indexed

About

Ofer Agid is a scholar working on Psychiatry and Mental health, Philosophy and Clinical Psychology. According to data from OpenAlex, Ofer Agid has authored 135 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Psychiatry and Mental health, 52 papers in Philosophy and 30 papers in Clinical Psychology. Recurrent topics in Ofer Agid's work include Schizophrenia research and treatment (106 papers), Mental Health and Psychiatry (52 papers) and Bipolar Disorder and Treatment (23 papers). Ofer Agid is often cited by papers focused on Schizophrenia research and treatment (106 papers), Mental Health and Psychiatry (52 papers) and Bipolar Disorder and Treatment (23 papers). Ofer Agid collaborates with scholars based in Canada, United States and Japan. Ofer Agid's co-authors include Gary Remington, George Foussias, Gagan Fervaha, Shitij Kapur, Robert B. Zipursky, Tamara Arenovich, Hiroyoshi Takeuchi, Bernard Lerer, Konstantine K. Zakzanis and Steven G. Potkin and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Ofer Agid

127 papers receiving 5.8k citations

Peers

Countries citing papers authored by Ofer Agid

Since Specialization

Citations

This map shows the geographic impact of Ofer Agid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Agid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Agid more than expected).

Fields of papers citing papers by Ofer Agid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Agid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Agid. The network helps show where Ofer Agid may publish in the future.

Co-authorship network of co-authors of Ofer Agid

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Agid. A scholar is included among the top collaborators of Ofer Agid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Agid. Ofer Agid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunities 2025 ·Expert Review of Neurotherapeutics ·Myrto Samara, (unknown), (unknown), (unknown), Dimitris Dikeos, (unknown), (unknown), (unknown), (unknown), C. Tsopelas, Ofer Agid	0
2	The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment 2025 ·Neurology and Therapy ·John M. Kane, Ofer Agid, David Castle, Leslie Citrome, Andrea Fagiolini, Taishiro Kishimoto, (unknown), Stefan Leucht, José M. Rubio, Martha Sajatovic, Nina R. Schooler, Christoph U. Correll	0
3	Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Corrélats cliniques des concentrations plasmiques de palipéridone à libération prolongée 2024 ·The Canadian Journal of Psychiatry ·Robert B. Zipursky, Ofer Agid, Michael Kiang, (unknown)	0
4	Who has poor insight, my patient suffering from schizophrenia or myself? 2023 ·European Neuropsychopharmacology ·Michael Davidson, Ofer Agid	2
5	Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder 2023 ·Neuroscience Applied ·Roger S. McIntyre, Ofer Agid, (unknown), (unknown)	1
6	When No Treatment Is the Treatment: Mental Illness–Related Case Report 2022 ·The Canadian Journal of Hospital Pharmacy ·(unknown), Ofer Agid	0
7	Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective Study 2021 ·The Canadian Journal of Psychiatry ·Ofer Agid, Gary Remington, (unknown), (unknown), (unknown), G Anger	9
8	Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implications 2021 ·Schizophrenia Research ·Hiroyoshi Takeuchi, Marcos Sanches, Carol Borlido, Ofer Agid, Gary Remington	1
9	Adherence to clozapine vs. other antipsychotics in schizophrenia 2020 ·Acta Psychiatrica Scandinavica ·Hiroyoshi Takeuchi, Carol Borlido, Marcos Sanches, Celine Teo, (unknown), Ofer Agid, Gary Remington	25
10	The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research 2020 ·Schizophrenia ·Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson, Oliver Howes	245
11	Reward-driven decision-making impairments in schizophrenia 2018 ·Schizophrenia Research ·(unknown), (unknown), Ishraq Siddiqui, Ofer Agid, Zafiris J. Daskalakis, Arun Ravindran, Aristotle N. Voineskos, Konstantine K. Zakzanis, Gary Remington, George Foussias	29
12	A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD) 2016 ·Journal of Psychiatric Research ·Hiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, Ofer Agid, Gary Remington	13
13	Life satisfaction and happiness among young adults with schizophrenia 2016 ·Psychiatry Research ·Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, George Foussias, Gary Remington	43
14	Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia 2015 ·Schizophrenia Research ·Gagan Fervaha, Christina L. Hill, Ofer Agid, Hiroyoshi Takeuchi, George Foussias, Ishraq Siddiqui, Robert S. Kern, Gary Remington	26
15	Impact of primary negative symptoms on functional outcomes in schizophrenia 2014 ·European Psychiatry ·Gagan Fervaha, George Foussias, Ofer Agid, Gary Remington	148
16	Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders 2013 ·European Neuropsychopharmacology ·George Foussias, Ofer Agid, Gagan Fervaha, Gary Remington	176
17	Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO 2011 ·Schizophrenia Research ·Romina Mizrahi, Ofer Agid, Carol Borlido, Ivonne Suridjan, Pablo Rusjan, Sylvain Houle, Gary Remington, Alan A. Wilson, Shitij Kapur	71
18	Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention 2010 ·Expert Opinion on Pharmacotherapy ·Ofer Agid, George Foussias, Gary Remington	66
19	MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA: CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS WITH FUNCTIONING 2010 ·Schizophrenia Research ·George Foussias, Steve Mann, Konstantine K. Zakzanis, Rob van Reekum, Ofer Agid, Gary Remington	2
20	Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission 2009 ·Journal of Psychiatric Research ·Terence A. Ketter, Ofer Agid, Shitij Kapur, Antony Loebel, Cynthia Siu, Steven J. Romano	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact